Stay updated with breaking news from Partial Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug...
Preliminary efficacy updated to 80% overall response rate (ORR) demonstrated in single agent AML trial following database lock Next generation anthracycline,...
08.12.2022 - Immunocore presents ovarian cancer expansion data for ImmTAC candidate IMC-C103C targeting MAGE-A4 Phase 1 trial enrolled all comers, with vast majority of patients having zero or very low MAGE-A4 expression IMC-C103C has a manageable safety ... Seite 1
30.11.2022 - TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) - Theralase Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic ...
Investegate announcements from Syncona Limited, Anaveon presents updated data from ANV419